Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 2, 2011 (rev. 1)


Complete Genomics has tapped Keith Raffel to serve as its chief commercial officer.

In addition to his duties as senior vice president at the company, Raffel will focus on identifying growth opportunities for Complete Genomics’ human genome sequencing services as well as explore ways to provide information and support to researchers and clinicians.

Prior to joining Complete Genomics, Raffel founded and served as chairman and CEO of cloud-computing company UpShot, where he designed the prototype for the company’s cloud-based CRM service. The business was eventually sold to Siebel Systems, where he remained on board as a group vice president.

He received his bachelor’s degree from Harvard College and obtained a master’s degree from the University of Oxford and a law degree from Harvard Law School.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.